2026-07-31
Nasdaq-listed biopharmaceutical company Enlivex has unveiled plans to raise up to $800 million to purchase RAIN tokens, a move that could dramatically dilute.
shareholder vote
Crypto News
Nasdaq-listed biopharmaceutical company Enlivex has unveiled plans to raise up to $800 million to purchase RAIN tokens, a move that could dramatically dilute.